LURAP1L

gene
On this page

Also known as MGC46502FLJ38505bA3L8.2LRAP35b

Summary

LURAP1L (leucine rich adaptor protein 1 like, HGNC:31452) is a protein-coding gene on chromosome 9p23, encoding Leucine rich adaptor protein 1-like (Q8IV03).

Predicted to be involved in positive regulation of canonical NF-kappaB signal transduction.

Source: NCBI Gene 286343 — RefSeq curated summary.

At a glance

  • GWAS associations: 5
  • Clinical variants (ClinVar): 77 total — 1 likely-pathogenic
  • MANE Select transcript: NM_203403

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31452
Approved symbolLURAP1L
Nameleucine rich adaptor protein 1 like
Location9p23
Locus typegene with protein product
StatusApproved
AliasesMGC46502, FLJ38505, bA3L8.2, LRAP35b
Ensembl geneENSG00000153714
Ensembl biotypeprotein_coding
OMIM616130
Entrez286343

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000319264, ENST00000489107

RefSeq mRNA: 1 — MANE Select: NM_203403 NM_203403

CCDS: CCDS6473

Canonical transcript exons

ENST00000319264 — 2 exons

ExonStartEnd
ENSE000012595351282138612823060
ENSE000012595601277502012776027

Expression profiles

Bgee: expression breadth ubiquitous, 222 present calls, max score 89.62.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.0360 / max 311.9629, expressed in 1233 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
9611313.04701184
961120.7587493
961140.230270

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
islet of LangerhansUBERON:000000689.62gold quality
calcaneal tendonUBERON:000370189.59gold quality
right lungUBERON:000216789.34gold quality
popliteal arteryUBERON:000225088.68gold quality
tibial arteryUBERON:000761088.66gold quality
upper lobe of left lungUBERON:000895287.67gold quality
upper lobe of lungUBERON:000894887.29gold quality
minor salivary glandUBERON:000183086.80gold quality
aortaUBERON:000094786.49gold quality
adrenal tissueUBERON:001830386.17gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.14gold quality
lungUBERON:000204885.76gold quality
gall bladderUBERON:000211085.74gold quality
muscle layer of sigmoid colonUBERON:003580585.67gold quality
left coronary arteryUBERON:000162685.31gold quality
right lobe of liverUBERON:000111485.17gold quality
saliva-secreting glandUBERON:000104484.98gold quality
transverse colonUBERON:000115784.10gold quality
pancreasUBERON:000126483.94gold quality
right coronary arteryUBERON:000162583.92gold quality
ascending aortaUBERON:000149683.87gold quality
thoracic aortaUBERON:000151583.80gold quality
coronary arteryUBERON:000162183.66gold quality
stromal cell of endometriumCL:000225583.48gold quality
colonUBERON:000115583.16gold quality
descending thoracic aortaUBERON:000234583.09gold quality
cerebellar cortexUBERON:000212983.02gold quality
cerebellar hemisphereUBERON:000224583.01gold quality
large intestineUBERON:000005982.98gold quality
rectumUBERON:000105282.87gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-8142yes41.57
E-HCAD-11yes23.94
E-ANND-3yes9.12

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

147 targeting LURAP1L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-9-5P100.0072.282361
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-428299.9975.366408
HSA-MIR-511-3P99.9968.851467
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-548P99.9872.253784
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-570-3P99.9672.414910
HSA-MIR-55999.9572.283609
HSA-MIR-548AB99.9571.313488
HSA-MIR-548Y99.9471.283514
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502
HSA-MIR-548AK99.9471.243488
HSA-MIR-548AM-5P99.9471.243488
HSA-MIR-548AP-5P99.9471.143489
HSA-MIR-548AQ-5P99.9471.343426
HSA-MIR-548AR-5P99.9471.283515
HSA-MIR-548AS-5P99.9471.223482
HSA-MIR-548AU-5P99.9471.243488
HSA-MIR-548AY-5P99.9471.233502
HSA-MIR-548B-5P99.9471.233502
HSA-MIR-548BB-5P99.9471.273509
HSA-MIR-548C-5P99.9471.243488

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusLurap1lENSMUSG00000048706
rattus_norvegicusLurap1lENSRNOG00000033740

Paralogs (1): LURAP1 (ENSG00000171357)

Protein

Protein identifiers

Leucine rich adaptor protein 1-likeQ8IV03 (reviewed: Q8IV03)

All UniProt accessions (1): Q8IV03

UniProt curated annotations — full annotation on UniProt →

Polymorphism. The poly-Gly region is polymorphic and the number of Gly varies in the population (from 9 to 12).

RefSeq proteins (1): NP_981948* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR037443LURAP1Family
IPR039499LURA1/LRA25Family

Pfam: PF14854

UniProt features (12 total): compositionally biased region 4, sequence variant 3, sequence conflict 2, chain 1, region of interest 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IV03-F166.080.24

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 1

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 109 (showing top): AAGCAAT_MIR137, GCANCTGNY_MYOD_Q6, GOZGIT_ESR1_TARGETS_DN, GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, AP4_Q6, CAGCTG_AP4_Q5, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, SOX9_B1, WANG_LMO4_TARGETS_DN, ENGELMANN_CANCER_PROGENITORS_UP, RIGGI_EWING_SARCOMA_PROGENITOR_DN, TCF11_01, MYOD_Q6, IRF_Q6, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION

GO Biological Process (1): positive regulation of canonical NF-kappaB signal transduction (GO:0043123)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
canonical NF-kappaB signal transduction1
regulation of canonical NF-kappaB signal transduction1
positive regulation of intracellular signal transduction1
binding1

Protein interactions and networks

STRING

450 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LURAP1LSLC4A3P48751454
LURAP1LUBE2G1P62253440
LURAP1LHYCC2Q8IXS8405
LURAP1LC10orf67Q8IYJ2394
LURAP1LWSCD2Q2TBF2380
LURAP1LERICH6BQ5W0A0372
LURAP1LADGRL2O95490371
LURAP1LFRMD7Q6ZUT3367
LURAP1LREELD1A0A1B0GV85359
LURAP1LADGRL3Q9HAR2352
LURAP1LKRTAP4-5Q9BYR2348
LURAP1LCDH20Q9HBT6340
LURAP1LWDR37Q9Y2I8336
LURAP1LCACNA2D1P54289335
LURAP1LAVL9Q8NBF6327

IntAct

24 interactions, top by confidence:

ABTypeScore
LURAP1LPATZ1psi-mi:“MI:0915”(physical association)0.560
FAM161ALURAP1Lpsi-mi:“MI:0915”(physical association)0.560
LURAP1LTBCCD1psi-mi:“MI:0915”(physical association)0.560
LURAP1LATPAF2psi-mi:“MI:0915”(physical association)0.560
SDCBPLURAP1Lpsi-mi:“MI:0915”(physical association)0.560
LURAP1LPRPHpsi-mi:“MI:0915”(physical association)0.560
CFTRLURAP1Lpsi-mi:“MI:0915”(physical association)0.370
NOD2LURAP1Lpsi-mi:“MI:0915”(physical association)0.370
LURAP1LSHTN1psi-mi:“MI:0914”(association)0.350
PATZ1LURAP1Lpsi-mi:“MI:0915”(physical association)0.000
FAM161ALURAP1Lpsi-mi:“MI:0915”(physical association)0.000
TBCCD1LURAP1Lpsi-mi:“MI:0915”(physical association)0.000
ATPAF2LURAP1Lpsi-mi:“MI:0915”(physical association)0.000
SDCBPLURAP1Lpsi-mi:“MI:0915”(physical association)0.000

BioGRID (36): KIAA1598 (Affinity Capture-MS), NEFM (Affinity Capture-MS), SNTB2 (Affinity Capture-MS), CDC42BPA (Affinity Capture-MS), CDC42BPB (Affinity Capture-MS), FBXO28 (Affinity Capture-MS), HSF1 (Affinity Capture-MS), SNAP29 (Affinity Capture-MS), TP53RK (Affinity Capture-MS), CDC42BPA (Affinity Capture-MS), CDC42BPB (Affinity Capture-MS), KIAA1598 (Affinity Capture-MS), FBXO28 (Affinity Capture-MS), HSF1 (Affinity Capture-MS), NEFM (Affinity Capture-MS)

ESM2 similar proteins: A1L168, A1L3T7, A6NGS2, A6QQF7, D4A8G3, O15049, P0C7N2, P0C7N4, P17257, P58660, Q08AY9, Q0V7M8, Q0VDN7, Q14BJ1, Q2NL23, Q3KP66, Q3LUD3, Q3UNU4, Q4LEZ3, Q566R4, Q571B6, Q5BJW5, Q5ND29, Q5RFZ7, Q5XIS1, Q6NSJ2, Q6P1G6, Q6Q0N2, Q7TN12, Q7TSI1, Q811W1, Q8BL43, Q8C7U1, Q8IV03, Q8K1S6, Q8K2P1, Q8N137, Q8N5H3, Q8TE77, Q8WWL2

Diamond homologs: D4A8G3, Q5BJW5, Q8IV03, Q8K2P1, Q96LR2, Q9D6I9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

77 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance70
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
916565NM_203403.2(LURAP1L):c.346C>T (p.Arg116Cys)Likely pathogenic

SpliceAI

602 predictions. Top by Δscore:

VariantEffectΔscore
9:12821383:TAG:Tacceptor_loss1.0000
9:12819140:GC:Gdonor_gain0.9900
9:12821377:T:TAacceptor_gain0.9900
9:12821384:A:AGacceptor_gain0.9900
9:12821384:AG:Aacceptor_gain0.9900
9:12821385:G:GAacceptor_gain0.9900
9:12821385:GG:Gacceptor_gain0.9900
9:12821385:GGTT:Gacceptor_gain0.9900
9:12821385:GGTTA:Gacceptor_gain0.9900
9:12775773:G:GGdonor_gain0.9800
9:12776024:GATG:Gdonor_gain0.9800
9:12776025:ATGG:Adonor_loss0.9800
9:12776027:GGT:Gdonor_loss0.9800
9:12776029:TGAG:Tdonor_loss0.9800
9:12776030:G:GGdonor_loss0.9800
9:12821382:ATAG:Aacceptor_gain0.9800
9:12821383:T:Gacceptor_gain0.9800
9:12821385:GGT:Gacceptor_gain0.9800
9:12775824:G:Tdonor_gain0.9700
9:12775825:A:Tdonor_gain0.9700
9:12776028:G:GGdonor_gain0.9700
9:12821382:A:AGacceptor_gain0.9700
9:12775298:G:Tdonor_gain0.9500
9:12776031:A:ACdonor_loss0.9500
9:12819141:C:Gdonor_gain0.9500
9:12819182:G:GGdonor_gain0.9500
9:12776019:C:Tdonor_gain0.9400
9:12821381:CATAG:Cacceptor_gain0.9400
9:12775264:T:TAdonor_gain0.9300
9:12775265:A:AAdonor_gain0.9300

AlphaMissense

1507 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000002502 (9:12773396 T>A), RS1000036050 (9:12803791 A>G), RS1000062683 (9:12799011 C>G,T), RS1000115524 (9:12809861 T>A), RS1000141355 (9:12809514 C>G), RS1000176334 (9:12800061 C>T), RS1000277798 (9:12814970 T>C), RS1000356017 (9:12780652 C>T), RS1000438701 (9:12780829 T>C), RS1000468702 (9:12800353 T>C), RS1000491975 (9:12817387 A>C,G), RS1000509741 (9:12822476 G>A,C), RS1000557585 (9:12777824 G>A), RS1000564710 (9:12790350 G>A), RS1000575735 (9:12823540 A>G)

Disease associations

OMIM: gene MIM:616130 | disease phenotypes: MIM:189960

GenCC curated gene-disease

Mondo (1): esophageal atresia/tracheoesophageal fistula (MONDO:0008586)

Orphanet (1): Esophageal atresia (Orphanet:1199)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

StudyTraitp-value
GCST002126_14Periodontitis (CDC/AAP)1.000000e-06
GCST003097_40Pediatric autoimmune diseases1.000000e-07
GCST003263_105Post bronchodilator FEV1 in COPD4.000000e-06
GCST003263_106Post bronchodilator FEV1 in COPD4.000000e-06
GCST009391_396Metabolite levels9.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004314forced expiratory volume
EFO:0010437triacylglycerol 58:10 measurement

MeSH disease descriptors (1)

DescriptorNameTree numbers
C531835Esophageal atresia with or without tracheoesophageal fistula (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

48 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cyclosporineincreases expression4
Benzo(a)pyreneincreases expression3
bisphenol Aaffects expression, increases expression2
sodium arsenitedecreases expression, increases expression2
Valproic Aciddecreases methylation, increases expression2
Cadmium Chloridedecreases expression, increases expression2
Particulate Matterincreases abundance, increases expression2
trichostatin Aincreases expression1
beta-lapachoneincreases expression1
methylparabenincreases expression1
butyraldehydedecreases expression1
didecyldimethylammoniumincreases expression1
nickel sulfateincreases expression1
1-nitropyreneincreases expression1
perfluorooctane sulfonic acidincreases expression1
2,2’,4,4’,5-brominated diphenyl etherincreases expression1
abrineincreases expression1
(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)increases expression1
NSC 689534affects binding, increases expression1
(+)-JQ1 compounddecreases expression1
NSC305787increases expression1
NSC668394increases expression1
Sunitinibdecreases expression1
Zoledronic Aciddecreases expression1
Leflunomideincreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicincreases methylation1
Azathioprineincreases expression1
Cannabidiolincreases expression1
Copperaffects binding, increases expression1

Clinical trials (associated diseases)

5 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT03792360PHASE1WITHDRAWNAdipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae
NCT02033772Not specifiedCOMPLETEDProspective Data Collection of Patients < 6 Months of Age Undergoing Thoracoscopic Surgery
NCT02364843Not specifiedTERMINATEDA Physiological Study to Determine the Enteral Threonine Requirements in Infants Aged 1 to 6 Months
NCT03455881Not specifiedUNKNOWNPhenotypic and Genetic Assessment of Tracheal and Esophageal Birth Defects in Patients
NCT03730454Not specifiedACTIVE_NOT_RECRUITINGTransanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair